Gatifloxacin 0.3% ophthalmic solution
198782-002
Phase 2 small_molecule completed
Quick answer
Gatifloxacin 0.3% ophthalmic solution for Acute Bacterial Corneal Ulcers is a Phase 2 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Acute Bacterial Corneal Ulcers
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed